Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
peanut allergy
Pharma
FDA approves Roche, Novartis' Xolair for common food allergies
On the market for two decades for asthma, Novartis and Roche’s Xolair has gained an FDA approval to prevent severe outcomes from food allergies.
Kevin Dunleavy
Feb 16, 2024 2:28pm
Roche's Xolair moves closer to food allergy approval from FDA
Dec 19, 2023 1:01pm
Palforzia gets new owner as Nestlé ditches peanut allergy drug
Sep 5, 2023 11:20am
Meet Neffy, the kid-friendly epinephrine nasal spray from ARS
Sep 3, 2021 11:27am
Alladapt starts work on immunotherapy plant near Philadelphia
Aug 20, 2021 9:55am
Nestlé lays out $2.1B for peanut allergy drugmaker Aimmune
Aug 31, 2020 10:27am
